Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice

British Journal of Nutrition

Volumn 108, Issue 2, 2012, Pages 218-228

  Nerurkar, Pratibha V ^a   Nishioka, Adrienne ^a   Eck, Philip O ^a   Johns, Lisa M ^a   Volper, Esther ^a   Nerurkar, Vivek R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Diabetes; FoxO1; Morinda citrifolia; Noni; Obesity

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR 1; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOXO1 GENE; FRUIT JUICE; G6PD GENE; GCK GENE; GENE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; INSULIN TOLERANCE TEST; LIPID DIET; LIVER METABOLISM; MALE; METABOLIC REGULATION; MICROARRAY ANALYSIS; MORINDA CITRIFOLIA; MOUSE; NONHUMAN; NONI FRUIT JUICE; NUCLEOTIDE SEQUENCE; OBESITY; PEPCK GENE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; THERAPY EFFECT; TRANSCRIPTION REGULATION; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; BEVERAGES; DIET, HIGH-FAT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; FRUIT; GLUCONEOGENESIS; GLYCOLYSIS; HEP G2 CELLS; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MORINDA; OBESITY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RANDOM ALLOCATION; RNA INTERFERENCE; RNA, MESSENGER;

MORINDA CITRIFOLIA; MUS;

EID: 84863855249     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005563     Document Type: Article

References (40)

1. McClatchey W (2002) From Polynesian healers to health food stores: changing perspectives of Morinda citrifolia (Rubiaceae). Integr Cancer Ther 1, 110-120. (Pubitemid 36834917)
2. Pawlus AD & Kinghorn DA (2007) Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J Pharm Pharmacol 59, 1587-1609. (Pubitemid 350221804)
3. Noni Biotech International (2011) All About Noni. http://nonimaui.com/ all.about.noni
4. Akihisa T, Matsumoto K, Tokuda H, et al. (2007) Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni). J Nat Prod 70, 754-757. (Pubitemid 46953594)
5. Furusawa E, Hirazumi A, Story S, et al. (2003) Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res 17, 1158-1164. (Pubitemid 38057172)
6. Li J, Stickel SL, Bouton-Verville H, et al. (2008) Fermented noni exudate (fNE): a mediator between immune system and anti-tumor activity. Oncol Rep 20, 1505-1509.
7. Wang MY, Anderson G & Nowicki D (2002) Preventive effect of Morinda citrifolia (Noni) at the initiation stage of mammary breast cancer induced by 7,12-dimethylbenz(a)-anthracen (DMBA) in female Sprague-Dawley rats. In The Proceedings of the Frontiers in Cancer Prevention Research, AACR, Boston, MA, USA, 17 October 2002.
8. Wang MY & Su C (2001) Cancer preventive effect of Morinda citrifolia (Noni). Ann N Y Acad Sci 952, 161-168. (Pubitemid 34060019)
9. Zhang X, Li J, Wong DK, et al. (2009) Fermented noni exudate-treated dendritic cells directly stimulate B lymphocyte proliferation and differentiation. Oncol Rep 21, 1147-1152.
10. Kamiya K, Hamabe W, Harada S, et al. (2008) Chemical constituents of Morinda citrifolia roots exhibit hypoglycemic effects in streptozotocin-induced diabetic mice. Biol Pharm Bull 31, 935-938. (Pubitemid 351732000)
11. Nayak BS, Isitor GN, Maxwell A, et al. (2007) Wound-healing activity of Morinda citrifolia fruit juice on diabetes-induced rats. J Wound Care 16, 83-86.
12. Soon YY & Tan BK (2002) Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Med J 43, 77-85. (Pubitemid 34534795)
13. Horsfall AU, Olabiyi O, Aiyegbusi A, et al. (2008) Morinda citrifolia fruit juice augments insulin action in Sprague-Dawley rats with experimentally induced diabetes. Nig Q J Hosp Med 18, 162-165.
14. Matsumoto M, Han S, Kitamura T, et al. (2006) Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116, 2464-2472. (Pubitemid 44330145)
15. Matsumoto M, Pocai A, Rossetti L, et al. (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6, 208-216. (Pubitemid 47336849)
16. Zhang W, Patil S, Chauhan B, et al. (2006) FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281, 10105-10117. (Pubitemid 43864546)
17. van der Heide LP, Hoekman MF & Smidt MP (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380, 297-309. (Pubitemid 38788101)
18. Aoyama H, Daitoku H & Fukamizu A (2006) Nutrient control of phosphorylation and translocation of Foxo1 in C57BL/6 and db/db mice. Int J Mol Med 18, 433-439.
19. Nerurkar PV, Lee YK, Motosue M, et al. (2008) Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br J Nutr 100, 751-759.
20. Nerurkar PV, Johns LM, Buesa LM, et al. (2011) Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J Neuroinflammation 8, 64.
21. Snee LS, Nerurkar VR, Dooley DA, et al. (2011) Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management. Nutr J 10, 78.
22. Vogt PK, Jiang H & Aoki M (2005) Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4, 908-913. (Pubitemid 41359756)
23. Gallou-Kabani C, Vige A, Gross M-S, et al. (2007) C57BL/6 and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 15, 1996-2005. (Pubitemid 47402231)
24. Haffner SM, Miettinen H & Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20, 1087-1092. (Pubitemid 27274268)
25. Seo K, Choi M-S, Jung UJ, et al. (2008) Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 52, 995-1004.
26. Bonora E, Targher G, Alberiche M, et al. (2000) Homeostasis model assessment closely mirror the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57-63.
27. Leighton B, Atkinson A & Coghlan MP (2005) Small molecule glucokinase activators as novel anti-diabetic agents. Biochem Soc Trans 33, 371-374. (Pubitemid 40604375)
28. Gorman T, Hope DCD, Brownlie R, et al. (2008) Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice. Diabetes Obes Metab 10, 885-897.
29. Frescas D, Valenti L & Accili D (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280, 20589-20595. (Pubitemid 40776761)
30. Ganjam GK, Dimova EY, Unterman TG, et al. (2009) FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol. J Biol Chem 284, 30783-30797.
31. Altomonte J, Richter A, Harbaran S, et al. (2003) Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 285, E718-E728. (Pubitemid 37176422)
32. Xia X, Yan J, Shen Y, et al. (2011) Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 6, e16556.
33. Oiso H, Furukawa N, Suefuji M, et al. (2011) The role of class I histone deacetylase (HDAC) on gluconeogeneis in liver. Biochem Biophys Res Commun 404, 166-172.
34. Mandukhail SU, Aziz N & Gilani AH (2010) Studies on antidyslipidemic effects of Morinda citrifolia (Noni) fruit, leaves and root extracts. Lipids Health Dis 9, 88.
35. Nayak BS, Marshall JR, Isitor G, et al. (2011) Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (Noni) in diabetic rats. Evid Based Complement Alternat Med 2011, 875293.
36. Dussossoy E, Brat P, Bony E, et al. (2010) Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). J Ethnopharmacol 133, 108-115.
37. Potterat O & Hamburger M (2007) Morinda citrifolia (Noni) fruit-phytochemistry, pharmacology, safety. Planta Med 73, 191-199. (Pubitemid 46917469)
38. Kampkotter A, Nkwonkam CG, Zurawski RF, et al. (2007) Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 234, 113-123. (Pubitemid 46517831)
39. Takikawa M, Inoue S, Horio F, et al. (2010) Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 140, 527-533.
40. Kampkotter A, Timpel C, Zurawski RF, et al. (2008) Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comp Biochem Physiol B Biochem Mol Biol 149, 314-323. (Pubitemid 350300012)